Article
Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Gastroenterology - 1 Aug 2010
Dohil Ranjan, Newbury Robert, Fox Lyman, Bastian John, Aceves Seema
Abstract excerpt
BACKGROUND & AIMS: Eosinophilic esophagitis (EoE) is caused by immunologic reactions to ingested/inhaled allergens. The diagnosis is considered if >or=15 eosinophils per high-powered field (eos/hpf) are detected in mucosal biopsies. Placebo-controlled studies have not been conducted to evaluate the safety and efficacy of oral viscous budesonide (OVB). METHODS: Children with EoE were randomly assigned to groups...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
